Strategies to Reduce Addiction Stigma Among Health Professionals
8. listopadu 2021 aktualizováno: Johns Hopkins Bloomberg School of Public Health
Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Professionals: A Randomized Experiment
The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.
Přehled studie
Postavení
Dokončeno
Intervence / Léčba
- Behaviorální: Words Matter - Visual Campaign
- Behaviorální: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) Experimental: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
- Behaviorální: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
- Behaviorální: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
- Behaviorální: Medication Treatment for Opioid Use Disorder Works - Visual Campaign
- Behaviorální: Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)
- Behaviorální: Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Clinician)
- Behaviorální: Medication Treatment for Opioid Use Disorder Works - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Detailní popis
This randomized experiment evaluated the impact of exposure to message frames communicating the importance of non-stigmatizing language regarding addiction and the effectiveness of medication treatment for opioid use disorder delivered through a visual campaign alone or through a visual campaign in addition to a narrative vignette from the perspective of one of three messengers (a person with opioid use disorder, a clinician, or a health system leader) on attitudes toward people with opioid use disorder and medications for treating opioid use disorder among a national sample of health professionals.
Typ studie
Intervenční
Zápis (Aktuální)
1842
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní místa
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21205
- Johns Hopkins Bloomberg School of Public Health
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
18 let a starší (Dospělý, Starší dospělý)
Přijímá zdravé dobrovolníky
Ano
Pohlaví způsobilá ke studiu
Všechno
Popis
Inclusion Criteria:
- employed as health professional in the United States, including clinicians (e.g., physicians, nurses, physician assistants, pharmacists, and optometrists), technicians and technologists (e.g., laboratory technologist or technician, emergency medical technician, paramedic, licensed practical or licensed vocational nurse, medical records or health information technician, etc.), health aids and assistants (e.g., nursing aide, home health aide, medical assistant, pharmacy aide, phlebotomist, etc.)
- participant in existing web-based survey panel (IPSOS's KnowledgeNetworks panel and partner opt-in panel)
Exclusion Criteria:
- not employed in health profession
- not able to complete experiment and survey in English
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Jiný
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Žádný zásah: No exposure control group
This group was not exposed to any message frame.
|
|
|
Experimentální: Words Matter - Visual Campaign
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings.
|
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings.
|
|
Experimentální: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a person with opioid use disorder.
|
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a person with opioid use disorder
|
|
Experimentální: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a clinician.
|
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a clinician working with patients with opioid use disorder
|
|
Experimentální: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
Participants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a health system administrator/leader.
|
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a health system administrator/leader
|
|
Experimentální: Medication Treatment Works - Visual Campaign
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives.
|
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives
|
|
Experimentální: Medication Treatment Works - Visual Campaign & Narrative Vignette (Person with OUD)
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a person with opioid use disorder.
|
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a person with opioid use disorder
|
|
Experimentální: Medication Treatment Works - Visual Campaign & Narrative Vignette (Clinician)
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a clinician.
|
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a clinician who treats people with opioid use disorder
|
|
Experimentální: Medication Treatment Works - Visual Campaign & Narrative Vignette (Health System Administrator)
Participants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a health system administrator/leader.
|
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a health system administrator/leader
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Rating of willingness to have person with opioid use disorder marry into their family
Časové okno: Measured immediately post-exposure to message frame intervention
|
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder marry into the family.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of willingness to have person with opioid use disorder as a neighbor
Časové okno: Measured immediately post-exposure to message frame intervention
|
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder as a neighbor.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of agreement that opioid use disorder is a medical condition
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement with statement "Opioid use disorder is a chronic medical condition like diabetes mellitus" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of agreement that individuals with opioid use disorder are to blame
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement with statement "Individuals with opioid use disorder only have themselves to blame for their problem" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of support for increasing government spending on opioid use disorder treatment
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of support for increasing government spending on treatment of opioid use disorder with 5 indicating strongly favoring and 1 indicating strongly opposing.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Feeling thermometer measure of warmth toward people with opioid use disorder
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of warmth felt toward people with opioid use disorder with 0 indicating extremely cold and 100 indicating extremely warm.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Stigmatizing Language - Addict
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "addict" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - Substance abuse
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "substance abuse" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - dirty
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "'dirty' in reference to the result from a drug test" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - clean
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "'clean' in reference to the result from a drug test" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - addicted baby
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "addicted baby" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - person with substance use disorder
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "person with substance use disorder" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - substance use
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "substance use" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - negative test result
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "negative test result" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - positive test result
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "positive test result" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Stigmatizing Language - baby born with neonatal opioid withdrawal syndrome
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement that term "baby born with neonatal opioid withdrawal syndrome" appropriate in a clinical care setting with 1 indicating strongly agree (that term is appropriate) and 5 indicating strongly disagree (that term is appropriate).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Willingness to sign pledge committing to using non-stigmatizing language
Časové okno: Measured immediately post-exposure to message frame intervention
|
Binary (yes/no) measure of whether participant is willing to sign a pledge committing to using non-stigmatizing language related to substance use disorder in clinical settings.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Perception of opioid use disorder treatment effectiveness
Časové okno: Measured immediately post-exposure to message frame intervention
|
Participant perception of whether there is a treatment for opioid use disorder that is effective for a long period of time (three close-ended response options: yes, there is a treatment; no, there isn't such a treatment; don't know).
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of willingness to have person taking medication marry into their family
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of willingness to have person taking medication to treat opioid use disorder marry into family.
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person taking medication to treat opioid use disorder marry into the family.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of willingness to have person taking medication marry as a neighbor
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of willingness to have person taking medication to treat opioid use disorder as a neighbor.
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person taking medication to treat opioid use disorder as a neighbor.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of strength/weakness of person taking medication
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of strength/weakness of person taking medication to treat opioid use disorder on 5-point Likert scale with 5 indicating strong and 1 indicating weak.
This is a semantic differential measure.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Rating of agreement that recovery is possible
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of agreement with statement "Most people with opioid use disorder will, with medication treatment, get well and return to productive lives" on a 5-point Likert scale with 5 indicating strongly disagree and 1 indicating strongly agree.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
|
Feeling thermometer measure of warmth toward people taking medication
Časové okno: Measured immediately post-exposure to message frame intervention
|
Rating of warmth felt toward people taking medication to treat opioid use disorder with 0 indicating extremely cold and 100 indicating extremely warm.
Measured via survey questionnaire.
|
Measured immediately post-exposure to message frame intervention
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Vyšetřovatelé
- Vrchní vyšetřovatel: Alene Kennedy-Hendricks, PhD, Johns Hopkins Bloomberg School of Public Health
Publikace a užitečné odkazy
Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Aktuální)
13. listopadu 2020
Primární dokončení (Aktuální)
30. listopadu 2020
Dokončení studie (Aktuální)
30. listopadu 2020
Termíny zápisu do studia
První předloženo
28. října 2021
První předloženo, které splnilo kritéria kontroly kvality
8. listopadu 2021
První zveřejněno (Aktuální)
19. listopadu 2021
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
19. listopadu 2021
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
8. listopadu 2021
Naposledy ověřeno
1. listopadu 2021
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Duševní poruchy
- Chemicky indukované poruchy
- Patologické procesy
- Poruchy související s narkotiky
- Poruchy související s látkami
- Choroba
- Poruchy související s opioidy
- Fyziologické účinky léků
- Depresiva centrálního nervového systému
- Agenti periferního nervového systému
- Analgetika
- Agenti smyslového systému
- Narkotika
- Analgetika, opiáty
Další identifikační čísla studie
- IRB14743
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
NE
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .